Rachel Dunscombe joined Visionable as its chief technology officer on Monday (30 March). Rachel is one of the best-known health tech leaders in the UK, as a result of her work with the NHS Digital Academy, the KLAS ARCH Collaborative, and Salford Royal NHS Foundation Trust. 
Buddy Healthcare wants to help hospitals and healthcare professionals in the battle against the COVID-19. BuddyCare virtual care platform can be used for not only symptom tracking, remote monitoring and data collection purposes but also in digitizing secure communication between the individuals/patients and healthcare professionals. 
Preventicus is proud to announce that the company continues to grow by bringing its unique, comprehensive care management programs for prevention of strokes and cardiovascular events to new international markets. By appointing Ljubisav Matejevic as Chief Sales and Marketing Officer and Member of the Executive Board, Preventicus strengthens its management team as well as its international focus. 
Highland Marketing will be returning to Digital Health Rewired this year, where it will be sponsoring the café that has been created with an expanded exhibition area.
Digital Health Rewired launched as a two-day leadership summit, conference and exhibition in 2019 and is returning to Olympia London on 3 and 4 March with a bigger programme and more exhibitors; many of them Highland Marketing clients.
Better is attending this year's Digital Health Rewired conference and exhibition at Olympia London alongside Taunton and Somerset NHS Foundation Trust, which is using its open platform to develop an electronic patient record.
The company will have a stand and a speaking slot at the leading industry event, and will use the opportunity to discuss the best way for trusts to make a success of the 'best of breed' approach to EPR with the UK health tech community.
Boehringer Ingelheim and Carebox Healthcare Solutions announced the recent launch of MyStudyWindow, a digital platform empowering patients, families, caregivers, and doctors to learn about Boehringer Ingelheim's studies by offering information in an easy to access and understandable way.